Doximity Inc
NYSE:DOCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Doximity Inc
NYSE:DOCS
|
US |
|
I
|
Installed Building Products Inc
SWB:2IL
|
US |
|
A
|
Accuray Inc
SWB:XEJ
|
US |
|
C
|
Canada Goose Holdings Inc
F:1GC
|
CA |
|
E
|
Endeavour Silver Corp
XHAM:EJD
|
CA |
|
M
|
Matas A/S
F:1MTA
|
DK |
Doximity Inc
Doximity is a digital network for medical professionals in the United States, especially doctors, nurses, and other clinicians. Its main products are a professional social network, messaging and telehealth tools, electronic faxing and workflow apps, and a news and reference feed tailored to healthcare workers. The company’s platform helps clinicians communicate with one another, manage patient-related tasks, and stay connected to medical information in one place. Doximity makes money mainly by selling access to its audience and workflow tools. Pharmaceutical companies, health systems, and other healthcare businesses pay to reach verified clinicians with targeted advertising, sponsorships, and recruiting or communications products. In effect, Doximity sits between the healthcare workforce and the companies that want to market to, hire, or communicate with that workforce. What makes the business unusual is that it is not a hospital system, insurer, or drug maker; it is a professional utility built around trusted identity and daily use by clinicians. That gives it a specialized role in healthcare communications and physician engagement. Its value comes from being a closed, credentialed network where the users are medical professionals and the customers are organizations that need direct access to them.
Doximity is a digital network for medical professionals in the United States, especially doctors, nurses, and other clinicians. Its main products are a professional social network, messaging and telehealth tools, electronic faxing and workflow apps, and a news and reference feed tailored to healthcare workers. The company’s platform helps clinicians communicate with one another, manage patient-related tasks, and stay connected to medical information in one place.
Doximity makes money mainly by selling access to its audience and workflow tools. Pharmaceutical companies, health systems, and other healthcare businesses pay to reach verified clinicians with targeted advertising, sponsorships, and recruiting or communications products. In effect, Doximity sits between the healthcare workforce and the companies that want to market to, hire, or communicate with that workforce.
What makes the business unusual is that it is not a hospital system, insurer, or drug maker; it is a professional utility built around trusted identity and daily use by clinicians. That gives it a specialized role in healthcare communications and physician engagement. Its value comes from being a closed, credentialed network where the users are medical professionals and the customers are organizations that need direct access to them.
Beat and raise: Doximity reported Q1 revenue of $157 million, up 7% year over year, and adjusted EBITDA of $75 million, both ahead of the high end of guidance. Management raised full-year revenue guidance by $6 million and lifted EBITDA guidance as AI spending steps up.
AI momentum: Usage of Doximity’s clinical AI tools is growing fast, with quarterly active workflow prescribers up more than 30% and AI prompt volume up more than 25% quarter over quarter.
Study win: Management leaned heavily on the NOHARM study, saying Doximity Ask delivered the lowest clinical error rates and highest safety ratings among U.S. models in the independent comparison.
Commercial traction: AI search is already helping open new conversations with pharma and hospital customers, and management said the majority of contracted AI search revenue will be recognized in Q3.
Investment year: The company said fiscal 2027 is an AI investment year, with higher compute and operating spend planned to support faster usage and future monetization.